I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 22% ± 6% | |
| basal cell | 6 studies | 24% ± 7% | |
| hematopoietic precursor cell | 5 studies | 32% ± 11% | |
| CD4-positive, alpha-beta T cell | 5 studies | 25% ± 14% | |
| erythroblast | 5 studies | 42% ± 20% | |
| epithelial cell | 5 studies | 35% ± 13% | |
| CD8-positive, alpha-beta T cell | 5 studies | 23% ± 11% | |
| natural killer cell | 4 studies | 23% ± 8% | |
| ciliated cell | 3 studies | 23% ± 3% | |
| dendritic cell | 3 studies | 32% ± 10% | |
| abnormal cell | 3 studies | 20% ± 3% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 43% ± 22% | |
| intestinal crypt stem cell | 3 studies | 23% ± 2% | |
| erythrocyte | 3 studies | 37% ± 15% | |
| transit amplifying cell | 3 studies | 26% ± 1% | |
| plasmacytoid dendritic cell | 3 studies | 18% ± 3% | |
| hematopoietic stem cell | 3 studies | 22% ± 1% |
